Switch to:
More From Other Websites
Repros Therapeutics, Inc. :RPRX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 27, 2016 Sep 27 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Sep 26 2016
FDA Schedules Advisory Committee Meeting To Discuss Secondary Hypogonadism Sep 26 2016
Repros Seeks EU Approval for Secondary Hypogonadism Drug Sep 13 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Sep 12 2016
Repros Announces Submission of MAA to the European Medicines Agency for Enclomiphene in the... Sep 12 2016
Repros Announces Submission of MAA to the European Medicines Agency for Enclomiphene in the... Sep 12 2016
Why Twitter, AMD and 2 Other Stocks Are in the Red Today, While Repros is Surging Sep 08 2016
Here’s What Latest Data Could Mean For Repros Therapeutics Inc (RPRX) Sep 08 2016
Why Repros Is Rising Sep 08 2016
Repros Therapeutics' (RPRX) Proellex Positive in Phase II Sep 08 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Sep 07 2016
Repros Provides Phase 2 Results Showing Positive Outcomes for Oral Proellex® in Women With Moderate... Sep 07 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Aug 18 2016
REPROS THERAPEUTICS INC. Financials Aug 17 2016
Repros Presents 6-Month Interim Data on Enclomiphene Aug 16 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events Aug 15 2016
Repros Provides Six Month Interim Results for Enclomiphene Study in Obese Secondary Hypogonadal Men Aug 15 2016
Repros (RPRX) Q2 Loss Narrower Y/Y, Focus on Pipeline Aug 10 2016
REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK